National Presto Industries boasts a diversified portfolio, balancing consumer products and defense. Read why I downgrade NPK stock from buy to hold.
CNBC Halftime Report analysts share their final trades, featuring bullish calls on NVIDIA, Robinhood, Snowflake, and CRH, along with recent analyst ratings and regulatory updates.
Atara Biotherapeutics (ATRA) stock slips as company faces an FDA clinical hold after rejection of lead candidate Ebvallo.
CFRA analyst Wan Nurhayati revised the price target for Novo Nordisk (NYSE:NVO) shares, reducing it to $90 from the previous target of $122. Despite the price target cut, the analyst retained a Hold ...